I am/have/had
I am looking for
Advanced Filters
Found 1 clinical trials
Immunological Biomarkers in Tuberculosis Management
Investigators propose to evaluate the performance in terms of diagnosis accuracy and outcome prediction of four new biomarkers of active TB: 1) a double IGRA (Interferon Gamma Release Assay) including QuantiFERON-Gold Plus and HBHA; 2) a whole blood transcriptomic analysis of mRNA (messenger Ribonucleic acid) expression of a panel of …
curb
immunophenotyping
interferon
interferon-gamma release assay
tuberculosis
- 0 views
- 16 Feb, 2024
- 1 location